Discussion on the use of taxanes for treatment of breast cancers in <it>BRCA1 </it>mutations carriers

Discussion on the use of taxanes for treatment of breast cancers in <it>BRCA1 </it>mutations carriers

Bibliographic Details
Format:	Article
Language:	English
Published:	BMC 2007-09-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/5/3/119

Similar Items

Mutations in BRCA2 and taxane resistance in prostate cancer
by: Cathleen Nientiedt, et al.
Published: (2017-07-01)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
by: Ellen Warner
Published: (2018-11-01)

Survival in Norwegian BRCA1 mutation carriers with breast cancer
by: Hagen Anne, et al.
Published: (2009-04-01)

Management of Breast Cancer in BRCA1/2 Mutation Carriers
by: R. A. Eeles, et al.
Published: (1999-01-01)

Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01)

Genetic modifiers of breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
by: Kuchenbaecker, Karoline Bernhardine Elisabeth Karla Ursula
Published: (2015)

Cancer risks in BRCA1 and BRCA2 mutation carriers
by: Thompson, Deborah Jane
Published: (2002)

Cisplatin in breast cancer treatment in BRCA1 carriers
by: Gronwald Jacek, et al.
Published: (2012-12-01)

Molecular biological subtypes of breast cancer in BRCA1 mutation carriers
by: N. I. Pospekhova, et al.
Published: (2021-01-01)

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers
by: Phillips KA, et al.
Published: (2012-04-01)

Comparison of risk assessment models of BRCA1 and BRCA2 mutation carrier in patients with breast cancer
by: Rybchenko L.A., et al.
Published: (2013-12-01)

Effect of Prior Bilateral Oophorectomy on the Presentation of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
by: Metcalfe Kelly A, et al.
Published: (2005-04-01)

Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
by: Kuchenbaecker, Karoline B, et al.
Published: (2014)

Mutation Analysis of BRCA1 and BRCA2 in Italian Hereditary and Sporadic Forms of Breast and Ovarian Cancers: Tumor Genotype-Phenotype Correlation in Breast Cancer BRCA-Mutation Carriers
by: G. Cipollini, et al.
Published: (1999-01-01)

No Sib Pair Concordance for Breast or Ovarian Cancer in <it>BRCA1 </it>Mutation Carriers
by: Møller Pål, et al.
Published: (2007-06-01)

Prostate cancer and targeted screening in BRCA1 and BRCA2 Mutation carriers
by: Mitra, Anita
Published: (2009)

Taxanes for the Treatment of Metastatic Breast Cancer
by: W.J. Gradishar
Published: (2012-10-01)

Taxanes for the Treatment of Metastatic Breast Cancer
by: W.J. Gradishar
Published: (2012-01-01)

Risk modelling in BRCA1 and BRCA2 mutation carriers
by: Mavaddat, Nasim
Published: (2012)

Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers
by: Randal L. Croshaw, et al.
Published: (2011-01-01)

Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in <i>BRCA1/BRCA2</i> Mutation Carriers Versus Non-Carriers
by: Michal Vocka, et al.
Published: (2019-05-01)

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
by: Petra van der Groep, et al.
Published: (2013-01-01)

RANKL/OPG in Breast Cancer — Extending Its Territory to BRCA Mutation Carriers
by: Tilman D. Rachner, et al.
Published: (2015-10-01)

A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
by: Juliette Coignard, et al.
Published: (2021-02-01)

Characteristics of breast cancer in BRCA1/BRCA2 mutation carriers and non-carriersfrom a genetic counseling unit in Croatia
by: Snježana Ramić, et al.
Published: (2020-01-01)

Breast cancer surveillance for BRCA1/2 mutation carriers – is “early detection” early enough?
by: Rinat Bernstein-Molho, et al.
Published: (2020-02-01)

Radiation induced DNA damage response in carriers of the breast cancer gene mutation BRCA1
by: Lamont, Jayne Margaret
Published: (2000)

Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers
by: Stawicka Małgorzata, et al.
Published: (2008-04-01)

A Cost Decision Model Supporting Treatment Strategy Selection in BRCA1/2 Mutation Carriers in Breast Cancer
by: Nunzia Carbonara, et al.
Published: (2021-08-01)

The Identification of BRCA1 and BRCA2 Mutation Carriers Using Functional Genomic Assays
by: Michel, CLAIRE S.
Published: (2008)

Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis.
by: Alexandra J van den Broek, et al.
Published: (2015-01-01)

Neoadjuvant chemotherapy with Cisplatin in BRCA1 mutation carriers – results of treatment
by: Byrski T, et al.
Published: (2012-04-01)

BRCA1 and BRCA2mutations in breast cancer patients from Venezuela
by: Karlena Lara, et al.
Published: (2012-01-01)

Familial breast cancer : are BRCA1 and BRCA2 mutations present in Scotland?
by: Renwick, A. A.
Published: (2002)

Diagnostic markers for the detection of ovarian cancer in BRCA1 mutation carriers.
by: Daphne Gschwantler-Kaulich, et al.
Published: (2017-01-01)

Clinical Considerations of BRCA1- and BRCA2-Mutation Carriers: A Review
by: O. Bougie, et al.
Published: (2011-01-01)

Effects of Radiation Therapy on Breast Epithelial Cells in BRCA1/2 Mutation Carriers
by: Huai-Chin Chiang, et al.
Published: (2015-06-01)

Risk-reducing salpingo-oophorectomy, natural menopause, and breast cancer risk: an international prospective cohort of BRCA1 and BRCA2 mutation carriers
by: Nasim Mavaddat, et al.
Published: (2020-01-01)

Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers
by: Juliette Coignard, et al.
Published: (2021-05-01)

Aromatase expression is increased in <it>BRCA1 </it>mutation carriers
by: Chand Ashwini L, et al.
Published: (2009-05-01)